NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

RepliCel Life Sciences Inc (V: RP)

 
RP Technical Analysis
5
As on 23rd Dec 2024 RP STOCK Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.11 & Strong Sell for SHORT-TERM with Stoploss of 0.18 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

RPSTOCK Price

Open 0.01 Change Price %
High 0.01 1 Day -0.01 -50.00
Low 0.01 1 Week 0.00 0.00
Close 0.01 1 Month -0.05 -83.33
Volume 10000 1 Year -0.11 -91.67
52 Week High 0.25 | 52 Week Low 0.01
 
V Canada Most Active Stocks
NU 14.06 -7.44%
WCU 0.05 -16.67%
QNC 0.66 24.53%
THRM 0.04 %
CANS 0.01 %
TORQ 0.06 0.00%
VTT 0.02 0.00%
PGM 0.02 0.00%
BTU 0.02 0.00%
VXTR 0.05 0.00%
 
V Canada Top Gainers Stocks
SML 1428.16 14281500.00%
SML 1428.16 14281500.00%
SML 1428.16 14281500.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
 
V Canada Top Losers Stocks
VEC 43.92 -99.71%
VEC 43.92 -99.71%
VEC 43.92 -99.71%
VEC 43.92 -99.71%
TZR 0.05 -75.00%
SGMA 4.18 -63.65%
SGMA 4.18 -63.65%
MEED-P 0.04 -60.00%
RP 0.01 -50.00%
RP 0.01 -50.00%
 
 
RP
Daily Charts
RP
Intraday Charts
Whats New @
Bazaartrend
RP
Free Analysis
 
RP Important Levels Intraday
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
 
RP Forecast December 2024
4th UP Forecast0.24
3rd UP Forecast0.17
2nd UP Forecast0.12
1st UP Forecast0.08
1st DOWN Forecast-0.06
2nd DOWN Forecast-0.1
3rd DOWN Forecast-0.15
4th DOWN Forecast-0.22
 
RP Weekly Forecast
4th UP Forecast0.05
3rd UP Forecast0.04
2nd UP Forecast0.03
1st UP Forecast0.02
1st DOWN Forecast0.00
2nd DOWN Forecast-0.01
3rd DOWN Forecast-0.02
4th DOWN Forecast-0.03
 
RP Forecast2024
4th UP Forecast0.47
3rd UP Forecast0.32
2nd UP Forecast0.23
1st UP Forecast0.14
1st DOWN Forecast-0.12
2nd DOWN Forecast-0.21
3rd DOWN Forecast-0.3
4th DOWN Forecast-0.45
 
 
RP Other Details
Segment EQ
Market Capital 10003824.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
RP Address
RP
 
RP Latest News
 
Your Comments and Response on RepliCel Life Sciences Inc
 
RP Business Profile
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01, which has completed Phase I clinical trials for the treatment of chronic tendinosis; RCS-01 that is in Phase 2 clinical trials to treat aging and sun damaged skin; and RCH-01, which is in Phase 2 clinical trials for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada. Address: 570 Granville Street, Vancouver, BC, Canada, V6C 3P1
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service